Keyphrases
Valsartan
100%
Heart Failure Trials
100%
Functional Parameters
100%
Physiological Parameters
100%
Mortality Parameters
100%
Nonelderly Patients
100%
Morbidity Mortality
100%
Non-elderly
46%
Beneficial Effects
30%
Quality of Life
23%
Left Ventricular Function
23%
Left Ventricular Size
23%
Brain Natriuretic Peptide
15%
Aldosterone
15%
Acute Decompensated Heart Failure
7%
Heart Failure
7%
Risk Reduction
7%
Placebo
7%
Heart Failure Therapy
7%
Heart Failure Hospitalization
7%
Treatment Effect
7%
Elderly Patients
7%
Clinical Significance
7%
High Mortality
7%
High Morbidity
7%
Neurohormonal
7%
Neurohormonal Activation
7%
Treatment Quality
7%
Life Effects
7%
Nursing and Health Professions
Elderly Patient
100%
Valsartan
100%
Congestive Heart Failure
100%
Quality of Life
23%
Noradrenalin
15%
Aldosterone
15%
Brain Natriuretic Peptide
15%
Post Hoc Analysis
7%
Placebo
7%
Prevalence
7%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Valsartan
100%
Noradrenalin
15%
Aldosterone
15%
Brain Natriuretic Peptide
15%
Placebo
7%
Prevalence
7%